MD HB546 | 2019 | Regular Session

Status

Spectrum: Partisan Bill (Republican 4-0)
Status: Introduced on February 4 2019 - 25% progression, died in chamber
Action: 2019-04-03 - Unfavorable Report by Health and Government Operations; Withdrawn
Text: Latest bill text (Introduced) [PDF]

Summary

Altering the definition of "specialty drug" for purposes of certain provisions of law governing access to specialty drugs through certain pharmacies to include a drug designated as a limited distribution drug, a drug that is not available in an oral or self-administered formulation, or a drug that requires special handling above and beyond refrigeration or patient counseling; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health Insurance - Access to and Coverage of Specialty Drugs - Definition

Sponsors


History

DateChamberAction
2019-04-03HouseUnfavorable Report by Health and Government Operations; Withdrawn
2019-02-13HouseHearing 3/07 at 1:00 p.m.
2019-02-04HouseFirst Reading Health and Government Operations

Subjects


Maryland State Sources


Bill Comments

feedback